Depo Brain Tumor Lawsuit: 2026 Updates and Payouts

Never Miss a Lawsuit Update

Mark Lawfold as a Preferred Source so you never miss a settlement deadline or new filing.

The depo brain tumor lawsuit is one of the fastest-growing mass torts in the United States right now. Thousands of women claim that Depo-Provera, a popular birth control shot made by Pfizer, caused them to develop meningioma brain tumors. These cases have been consolidated into a federal MDL, and 2026 is shaping up to be the year things really start moving.

If you used Depo-Provera and later received a brain tumor diagnosis, this article covers everything you need to know. You’ll find 2026 case updates, settlement projections, eligibility rules, and filing deadlines.

One striking detail: a 2024 BMJ study found that women who used Depo-Provera for more than three years had a 5.6 times higher risk of developing intracranial meningiomas. That single finding changed everything.

You might also find this useful — James Henry Lawsuit 2026: Full Settlement and Claim Guide

Depo Brain Tumor Lawsuit Overview

The depo brain tumor lawsuit involves claims that Pfizer’s injectable birth control, Depo-Provera, increases the risk of meningioma brain tumors. Plaintiffs say Pfizer knew about this risk and failed to warn patients or doctors.

Depo-Provera contains medroxyprogesterone acetate, a synthetic form of progesterone. Women receive the shot every three months to prevent pregnancy. The drug has been on the market since 1992 and has been used by millions of women worldwide.

The core allegation is straightforward. Pfizer did not include brain tumor warnings on the Depo-Provera label, even after scientific evidence pointed to a connection. Lawsuits began picking up steam in 2024 and have accelerated sharply.

The lawsuit is not about one bad batch or a manufacturing defect. It’s about whether Pfizer had a duty to warn women that long-term use of this drug could grow tumors in their brains.

Depo-Provera Brain Tumor Lawsuit Update for 2026

As of 2026, the Depo-Provera brain tumor lawsuit is in active pretrial proceedings within a federal multidistrict litigation. Judge Liles C. Burke in the Northern District of Alabama is overseeing MDL No. 3127.

New cases continue to be filed on a weekly basis. By early 2026, the MDL docket has swelled to well over 3,000 individual claims. That number is expected to keep rising throughout the year.

Several key developments happened in late 2025 and early 2026:

• Discovery phase is underway, with plaintiffs demanding internal Pfizer documents
• Expert witness disclosures have been exchanged by both sides
• A bellwether trial selection process has begun to identify test cases
• Pfizer filed motions to exclude certain scientific studies, which the court is evaluating

The pace of this litigation tells you something important. Courts don’t move this fast unless the evidence is serious and the volume of cases demands attention.

Think of bellwether trials like test runs. They help both sides figure out what a jury thinks of the evidence before thousands of cases go to trial.

What the Depo-Provera Lawsuit Means in 2026

The year 2026 is a turning point for this litigation. Bellwether trials are likely to be scheduled, and the first trial outcomes will set the tone for any settlement talks.

For women who used Depo-Provera, 2026 matters because the legal window for filing may be narrowing. Statutes of limitations vary by state, and waiting too long could mean losing the right to seek compensation entirely.

Here’s what 2026 specifically brings to the table:

• Bellwether trial dates are anticipated in late 2026 or early 2027
• Settlement negotiations could begin after the first trial verdicts
• The FDA may update its labeling guidance for Depo-Provera
• More scientific research is expected to be published, strengthening plaintiffs’ arguments

If you’ve been waiting to see how this plays out, 2026 will give you answers. But don’t wait too long to protect your rights.

Key Takeaway: The depo brain tumor lawsuit is accelerating in 2026, with bellwether trials on the horizon and thousands of new claims being filed each month.

Depo-Provera Meningioma Lawsuit Explained

A meningioma is a tumor that forms on the membranes covering the brain and spinal cord. The Depo-Provera meningioma lawsuit claims that this specific type of tumor is directly linked to prolonged use of the birth control shot.

Most meningiomas are classified as benign, meaning they are not cancerous. But calling them “benign” can be misleading. These tumors can grow large enough to compress brain tissue, cause seizures, impair vision, and require major surgery.

Plaintiffs argue that meningioma cells contain progesterone receptors. Depo-Provera floods the body with synthetic progesterone every three months. Over time, this hormonal exposure may fuel abnormal cell growth in the brain.

• Meningiomas account for roughly 40% of all primary brain tumors
• They are more common in women than men
• The connection to progestin-based drugs has been studied for over a decade
• Depo-Provera delivers one of the highest doses of synthetic progesterone among contraceptives

The lawsuit does not claim that every woman who uses Depo-Provera will develop a meningioma. It claims that Pfizer should have warned women about the elevated risk so they could make informed decisions.

The Connection Between Depo and Brain Tumor Lawsuits

The link between Depo-Provera and brain tumors is supported by multiple peer-reviewed studies. This isn’t speculation. It’s science that Pfizer allegedly ignored.

The most important study came from the BMJ in March 2024. Researchers analyzed data from over 18,000 women with intracranial meningiomas. They found that prolonged use of injectable progestins like Depo-Provera was associated with a 5.6-fold increased risk of developing these tumors.

An earlier French study, published in 2021, had already flagged the risk. That research used France’s national health insurance database and found similar patterns among women taking high-dose progestin medications.

Here’s a quick breakdown of the key research:

Pfizer’s defense will likely argue that the studies don’t prove direct causation. But for juries, the pattern is hard to dismiss when multiple independent research teams reached similar conclusions.

Depo-Provera Side Effects and Brain Tumors

Depo-Provera has a long list of known side effects, but brain tumors were not among the warnings until very recently. Common side effects include weight gain, irregular bleeding, bone density loss, and mood changes.

The brain tumor connection is different from these typical side effects. It involves a slow-growing tumor that may not show symptoms for years. Many women don’t learn about their meningioma until a decade or more after starting Depo-Provera.

Symptoms of meningioma that Depo-Provera users should watch for:

• Persistent headaches that worsen over time
• Vision changes, including blurriness or double vision
• Hearing loss or ringing in the ears
• Seizures with no prior history
• Memory problems or difficulty concentrating
• Weakness in arms or legs

Quick Fact: The average time between starting Depo-Provera and a meningioma diagnosis is estimated at 7 to 15 years, based on reported cases in the MDL.

What makes this side effect especially troubling is the delay. A woman might stop using Depo-Provera and assume she’s fine. Years later, an MRI reveals a tumor that has been growing silently.

Key Takeaway: Brain tumors from Depo-Provera can take years to appear, which is why many women are only now connecting their diagnosis to a drug they used a decade ago.

How Meningioma From Depo-Provera Develops

Meningioma from Depo-Provera develops because the drug delivers high levels of synthetic progesterone directly into the body. Meningioma cells are known to carry progesterone receptors, which means the hormone can stimulate their growth.

Think of it like watering a plant you didn’t know was there. The tumor cells may already exist in small numbers. The constant supply of progesterone acts like fertilizer, encouraging them to multiply and form a detectable mass.

Here’s how the biological process works:

• Step 1: Depo-Provera injects 150 mg of medroxyprogesterone acetate every 12 weeks
• Step 2: The synthetic progesterone circulates through the bloodstream
• Step 3: Meningioma cells with progesterone receptors absorb the hormone
• Step 4: The hormone triggers cell proliferation in the meninges
• Step 5: Over months or years, a tumor grows large enough to cause symptoms

The dose matters. Depo-Provera delivers a significantly higher dose of progestin compared to oral contraceptives. A typical birth control pill might contain 1 to 10 mg of progestin per dose. Depo-Provera delivers 150 mg in a single injection.

That massive dose difference is central to the lawsuits. Plaintiffs argue that the concentration of progestin in Depo-Provera makes it uniquely dangerous compared to other hormonal contraceptives.

Depo-Provera Lawsuit Eligibility Requirements

To be eligible for the Depo-Provera lawsuit, you generally need two things: a history of using Depo-Provera and a diagnosis of meningioma or another intracranial tumor. The details matter, though, so here’s a closer look.

Most law firms and the MDL are focused on cases where the plaintiff used Depo-Provera for at least one year. Some firms accept cases with shorter usage periods if the tumor is particularly severe or required surgery.

Basic eligibility requirements include:

• You received Depo-Provera injections (at least 4 shots, roughly one year of use)
• You were diagnosed with a meningioma or intracranial brain tumor
• Your diagnosis came during or after your use of Depo-Provera
• You have medical records documenting both the drug use and the diagnosis

Cases involving surgery, radiation, or significant neurological damage tend to be valued higher. But even women who are on a “watch and wait” monitoring plan may still qualify.

You don’t need to have used Depo-Provera recently. Women who took the shot in the 1990s or 2000s and were later diagnosed are filing claims right now.

Who Qualifies for the Depo-Provera Lawsuit

Anyone who used Depo-Provera and was later diagnosed with a meningioma may qualify for this lawsuit. The key is connecting the drug use to the tumor through medical evidence.

Several groups of people are currently filing claims:

• Women who used Depo-Provera for 1 or more years and developed meningioma
• Women who had brain surgery to remove a tumor after using Depo-Provera
• Family members of deceased women whose death was related to a meningioma (wrongful death claims)
• Women currently under surveillance for a diagnosed but untreated meningioma

You don’t need to prove that Depo-Provera was the only possible cause of your tumor. You need to show that it was a substantial contributing factor. Your attorney and medical experts handle that part.

Quick Fact: Women who used Depo-Provera for 3 or more years have the strongest cases, based on the BMJ study showing a 5.6x risk increase in that group.

If you’re unsure whether you qualify, the simplest first step is gathering your medical records. Look for injection records from your gynecologist or primary care doctor, along with MRI or CT scan reports showing the tumor.

If you're curious, also see Finance Lawsuit April 2026: Settlement and Payout Updates

Key Takeaway: You qualify for the Depo-Provera lawsuit if you used the drug for at least a year and have a documented brain tumor diagnosis, even if the diagnosis came years after you stopped the injections.

Depo-Provera Lawsuit Settlement Amounts

No settlements have been finalized yet in the Depo-Provera brain tumor lawsuit as of 2026. The cases are still in pretrial litigation, so all numbers at this stage are estimates based on similar pharmaceutical mass torts.

Legal analysts and attorneys handling these cases have projected settlement ranges based on injury severity. The more severe your injury, the higher the potential compensation.

These are projections, not guarantees. Actual settlement amounts will depend on bellwether trial outcomes, the strength of the scientific evidence presented to juries, and Pfizer’s willingness to negotiate.

For context, the Zantac MDL and talcum powder lawsuits offer useful comparisons. In those cases, individual payouts ranged from tens of thousands to millions of dollars depending on injury severity.

Settlement talks are unlikely to begin in earnest until at least one bellwether trial produces a verdict. That’s expected in late 2026 or early 2027.

Depo-Provera Lawsuit Payout Per Person

The payout per person in a Depo-Provera lawsuit will vary widely based on individual circumstances. There is no flat payment that everyone receives.

Factors that will determine your individual payout include:

• Severity of the tumor (size, location, growth rate)
• Type of treatment required (surgery, radiation, watchful waiting)
• Duration of Depo-Provera use (longer use strengthens the claim)
• Lasting effects on your health (neurological deficits, disability, lost income)
• Age at diagnosis (younger patients may receive more for lifetime impact)
• Quality of documentation (medical records, pharmacy records)

A woman who had a craniotomy to remove a large meningioma and now lives with vision loss will receive a much larger payout than someone with a small, asymptomatic tumor found on a routine scan.

It’s worth understanding that mass tort payouts don’t work like lottery winnings. Each case is evaluated individually. Your attorney negotiates your specific claim based on your specific damages.

Is the Depo-Provera Case a Class Action Lawsuit?

The Depo-Provera brain tumor case is not a class action lawsuit. It is a mass tort organized as a multidistrict litigation, which works differently in important ways.

In a class action, one plaintiff represents an entire group, and everyone gets the same payout. In a mass tort MDL, each person files their own individual lawsuit. Your case is yours. Your evidence matters. Your payout is based on your specific situation.

Here’s the difference at a glance:

Many people search for “Depo-Provera class action” because it’s a familiar term. But understanding that this is an MDL actually works in your favor. It means your compensation will reflect your actual injuries rather than being diluted across thousands of people.

Key Takeaway: The Depo-Provera case is an MDL, not a class action, which means each plaintiff’s injuries are evaluated and compensated individually.

Depo-Provera MDL: How the Federal Cases Are Organized

The Depo-Provera MDL (Multidistrict Litigation No. 3127) is centralized in the U.S. District Court for the Northern District of Alabama. Judge Liles C. Burke was assigned to oversee all federally filed cases.

The U.S. Judicial Panel on Multidistrict Litigation (JPML) created this MDL in 2024 after dozens of similar lawsuits were filed across the country. Consolidation makes the process more efficient by having one judge handle pretrial matters like discovery, expert challenges, and motions.

Here’s how the MDL process flows:

• Step 1: Individual lawsuits are transferred to the MDL court
• Step 2: Pretrial discovery is conducted (document requests, depositions, expert reports)
• Step 3: Bellwether cases are selected for trial
• Step 4: Bellwether trials take place to test evidence and gauge jury reactions
• Step 5: Based on trial results, parties may negotiate a global settlement
• Step 6: If no settlement, cases are sent back to their original courts for individual trials

The MDL doesn’t prevent you from filing a state court lawsuit instead. Some plaintiffs and their attorneys choose state courts for strategic reasons, depending on the jurisdiction.

The Depo-Provera Pfizer Lawsuit and Manufacturer Liability

Pfizer is the primary defendant in the Depo-Provera brain tumor lawsuits. The company manufactures and markets the drug, making it legally responsible for the product’s safety labeling.

Plaintiffs allege that Pfizer committed a “failure to warn.” This means the company knew or should have known about the brain tumor risk but did not update the drug’s label or inform healthcare providers.

The legal theory goes like this:

• Scientific studies linking progestins to meningioma have existed since the early 2000s
• Regulatory agencies in France began restricting similar drugs years before the U.S. took action
• Pfizer had access to adverse event reports and safety data
• Despite all of this, the U.S. Depo-Provera label did not include a meningioma warning until recently

Pfizer acquired the rights to Depo-Provera through its purchase of Pharmacia & Upjohn. The company has defended the drug publicly, stating that it meets FDA requirements and that the scientific evidence does not establish definitive causation.

Quick Fact: France’s drug safety agency restricted the use of certain high-dose progestin products, including some related to Depo-Provera’s active ingredient, starting in 2020 due to meningioma concerns.

Pfizer’s position will be tested in bellwether trials. If juries side with plaintiffs, the pressure on Pfizer to settle will increase dramatically.

Key Takeaway: Pfizer faces “failure to warn” claims arguing the company hid or ignored brain tumor risks associated with Depo-Provera for years.

How to File a Depo-Provera Lawsuit

Filing a Depo-Provera lawsuit starts with contacting a law firm that handles pharmaceutical mass torts. Most firms offer free case evaluations and work on contingency, meaning you pay nothing upfront.

Here’s the general step-by-step process:

• Step 1: Gather your medical records showing Depo-Provera use (injection records, pharmacy records)
• Step 2: Collect documentation of your brain tumor diagnosis (MRI reports, pathology reports, surgical records)
• Step 3: Contact a mass tort attorney for a free case review
• Step 4: The attorney evaluates your case and determines if it meets eligibility requirements
• Step 5: If accepted, the attorney files your complaint in the MDL or in state court
• Step 6: Your case enters the pretrial process alongside thousands of others

You do not need to remember exact dates of every injection. Pharmacy databases and medical records can often be retrieved going back 10 to 20 years.

Most attorneys take these cases on a contingency fee basis. That means they get paid a percentage of your settlement or verdict, typically 30% to 40%. If you don’t win, you don’t pay.

Depo-Provera Bellwether Trial Schedule

Bellwether trials are expected to begin in late 2026 or early 2027 in the Depo-Provera MDL. These are the first cases to go before a jury, and their outcomes will shape the entire litigation.

The bellwether selection process is already underway in 2026. Both sides, plaintiffs and Pfizer, will agree on a small group of representative cases. These cases are chosen because they reflect different types of injuries and usage patterns common in the broader MDL.

How bellwether trials work:

Worth reading: Fiserv Lawsuit 2026: What Merchants Need to Know

• A small number of cases (typically 4 to 10) are selected
• These cases go through full trial preparation, including expert testimony
• Juries hear the evidence and deliver verdicts
• The verdicts don’t bind other plaintiffs but signal how future juries might rule
• Strong plaintiff verdicts push the defendant toward settlement negotiations
• Strong defense verdicts may reduce settlement values

Bellwether results are like a preview for both sides. If Pfizer loses big in the first trials, they’ll have strong motivation to settle the remaining cases rather than face thousands of individual jury verdicts.

Depo-Provera Lawsuit Deadline in 2026

There is no single national deadline for filing a Depo-Provera brain tumor lawsuit. Filing deadlines depend on your state’s statute of limitations and when you discovered (or should have discovered) your injury.

Most states have a 2 to 3 year statute of limitations for personal injury claims. But the clock doesn’t always start on the date of your last injection. In many states, the “discovery rule” applies, meaning the clock starts when you knew or should have known that Depo-Provera caused your brain tumor.

Don't miss this — Live Olympics Lawsuit 2026: Settlement and Filing Update

Because this litigation became widely known in 2024, many states will consider the discovery clock to have started around that time. This means some filing windows could close as early as 2026.

Quick Fact: If your state has a 2-year statute of limitations and you learned about the Depo-Provera brain tumor connection in 2024, your deadline to file could be as soon as 2026.

Don’t assume you have unlimited time. The safest move is to file sooner rather than later.

Key Takeaway: Filing deadlines vary by state, but some women may lose their right to sue as early as 2026 if they don’t act on their claims promptly.

Depo-Provera Statute of Limitations by State

The statute of limitations for a Depo-Provera brain tumor lawsuit varies from state to state. This is one of the most common questions women ask, and the answer depends on where you live and when you discovered the link between the drug and your tumor.

Every state has its own personal injury statute. The range is typically 1 to 6 years, with most states falling in the 2 to 3 year window.

Some states also have a “statute of repose,” which sets an absolute outer deadline regardless of when you discovered the injury. This can be anywhere from 6 to 12 years after the last exposure to the drug.

The discovery rule is your friend if you only recently learned about the brain tumor risk. It protects people who couldn’t have reasonably known about the danger until the scientific evidence became public.

However, the statute of repose can shut the door even if you just found out. If you took your last Depo-Provera shot 15 years ago in Texas, for instance, the statute of repose may have already expired.

An experienced attorney can evaluate your specific state’s rules and determine whether your claim is still timely. This is one area where procrastination can be genuinely costly.

Frequently Asked Questions

Can I still file a depo brain tumor lawsuit in 2026?

Yes, many women can still file a depo brain tumor lawsuit in 2026.

Your eligibility depends on your state’s statute of limitations and when you discovered the connection between Depo-Provera and your tumor.

States with a 2-year statute may have deadlines closing in 2026, so filing soon is a smart move.

How much money can I get from a Depo-Provera lawsuit?

Settlement amounts are projected to range from $25,000 to $750,000 or more per person.

Your payout depends on injury severity, whether surgery was required, and how long you used the drug.

No settlements have been finalized yet as of 2026.

Does Depo-Provera actually cause brain tumors?

Multiple peer-reviewed studies have linked Depo-Provera to meningioma brain tumors.

A 2024 BMJ study found a 5.6 times higher risk in women using injectable progestins for over three years.

The lawsuits allege Pfizer knew about this risk and failed to warn patients.

What is the difference between the Depo-Provera MDL and a class action?

The Depo-Provera case is an MDL, not a class action.

In an MDL, each person files their own individual lawsuit and receives compensation based on their specific injuries.

In a class action, one payout covers the entire group equally.

How long does a Depo-Provera brain tumor lawsuit take?

Most mass tort lawsuits take 2 to 5 years from initial filing to resolution.

Bellwether trials are expected in late 2026 or early 2027, and settlements could follow if those trials favor plaintiffs.

Individual timelines vary based on your case specifics and the overall pace of the MDL.

Take Action Before Your Window Closes

The Depo-Provera brain tumor lawsuit is moving quickly in 2026. Bellwether trials are on the horizon, and filing deadlines are approaching in several states.

If you used Depo-Provera and were diagnosed with a meningioma, now is the time to gather your medical records and speak with an attorney. The evidence supporting these claims grows stronger every year.

Don’t let a filing deadline pass you by. Your case has a clock, and it’s already running.

Don't miss this — Black Farmers Lawsuit 2026: Status, Pay & Who Qualifies

You may want to read Ekstensive Metal Works Lawsuit: Full 2026 Update

Explore this too: Reed-Nelson Lawsuit 2026: Settlement and Payout Guide

Never Miss a Lawsuit Update

Mark Lawfold as a Preferred Source so you never miss a settlement deadline or new filing.